In esophageal squamous cell carcinoma, pharmacological inhibition of PAK1 reduces cancer cell migration and invasion as well as matrix metalloproteinase (MMP)-2 and MMP-9 expression [51]. This evidence concerns the gene MMP2 and esophageal squamous cell carcinoma.